IN BRIEF: Physiomics chair steps down after 15 years; CEO adds role

Archived article

Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.

Physiomics PLC - oncology consultancy based in Oxford, England - Non-Executive Chair Paul Harper steps down from board immediately, having served on the board since 2004 and as chair since 2007. Chief Executive Officer Jim Millen will take on the additional role of executive chair. Physiomics also will recruit one independent non-executive director "as soon as possible".

Current stock price: 5.00 pence, down 1.0% on Wednesday
12-month change: down 34%

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.